Authors: | Moskowitz, C. H.; Zelenetz, A.; Schoder, H. |
Article Title: | An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma |
Abstract: | A significant amount of literature is available on treatment monitoring and response assessment in lymphoma using FDG-PET, yet confusion exists concerning the potential and limitations of FDG-PET for determining the presence of residual disease during chemotherapy (interim FDG-PET). This article reviews the role of interim FDG-PET in 3 important scenarios: untreated diffuse large B-cell lymphoma, untreated Hodgkin lymphoma, and relapsed or refractory aggressive lymphoma in transplant-eligible patients, and provides recommendations on the use of this imaging modality in these settings. © Journal of the National Comprehensive Cancer Network. |
Keywords: | event free survival; treatment outcome; treatment failure; prednisone; doxorubicin; cancer radiotherapy; rituximab; positron emission tomography; follow up; neoplasm staging; sensitivity and specificity; radiopharmaceuticals; carboplatin; dacarbazine; progression free survival; multiple cycle treatment; etoposide; cyclophosphamide; vincristine; autologous stem cell transplantation; stem cell transplantation; risk factor; ifosfamide; procarbazine; vinblastine; hodgkin disease; b cell lymphoma; fluorodeoxyglucose f18; positron-emission tomography; bleomycin; vindesine; large cell lymphoma; lymphoma, large b-cell, diffuse; fluorodeoxyglucose; diffuse large b-cell lymphoma; hodgkin lymphoma; gallium; interim fdg-pet |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 8 |
Issue: | 3 |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2010-03-01 |
Start Page: | 347 |
End Page: | 352 |
Language: | English |
PUBMED: | 20202464 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 2" - "Export Date: 20 April 2011" - "Source: Scopus" |